title: NHS generic project: response from the wound care community.
abstract: This series of letters outlines the response from MA Healthcare, key opinion leaders and industry to the news that the Government is planning to introduce a generic project for wound dressings.
authors.affiliation: Publishing Director, MA Healthcare.
authors.forename: Anthony
authors.initials: A
authors.lastname: Kerr
authors.affiliation: Catalyst Health Economics Consultants, Northwood, Middlesex, UK & Faculty of Life Sciences and Medicine, King's College, London.
authors.forename: Julian F
authors.initials: JF
authors.lastname: Guest
authors.affiliation: Bradford Teaching Hospitals NHS Foundation Trust and University of Bradford.
authors.forename: Peter
authors.initials: P
authors.lastname: Vowden
authors.affiliation: Professor of Tissue Viability, Institute of Health and Society, University of Worcerster, St. John's Campus, Worcester.
authors.forename: Richard
authors.initials: R
authors.lastname: White
authors.affiliation: Head of Podiatry, Solent NHS Trust.
authors.forename: Graham
authors.initials: G
authors.lastname: Bowen
authors.affiliation: Lead Nurse Tissue Viability, Kettering General Hospital NHS Foundation Trust. Deputy Chair EMTVG.
authors.forename: C
authors.initials: C
authors.lastname: Iversen
authors.affiliation: CEO on behalf of Crawford Healthcare Ltd.
authors.forename: Richard
authors.initials: R
authors.lastname: Anderson
mesh_terms: D006801:Humans; D017410:Practice Guidelines as Topic; D011787:Quality of Health Care; D017592:Skin Care; D012883:Skin Ulcer / Q000451:nursing / Q000517:prevention & control*; D013222:State Medicine; D006113:United Kingdom